Clinical trial · Interventional
PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage
Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage After Low Anterior Resection in Patients With Rectal Cancer: A Randomized Clinical Trial(PALARC 02)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Surgical resection remains the primary treatment for rectal cancer, but the postoperative incidence of anastomotic leakage (AL) is relatively high. AL not only increases the medical burden on patients, prolongs hospital stays, raises the need for secondary surgery, and elevates perioperative mortality, but also increases the long-term risk of local recurrence and reduces survival rates. There is an urgent need for a simple, effective treatment method that minimizes the burden on patients to prevent anastomotic leakage. The preoperative placement of a transanal drainage tube (TDT) is believed to effectively drain gas and feces from the intestinal lumen, thereby reducing intestinal pressure and alleviating tension at the anastomotic site, thus preventing AL. Previous studies have shown that traditional drainage tubes cannot effectively prevent leakage. Given the limitations of existing research on traditional TDTs, we plan to use a modified TDT (which allows postoperative irrigation and utilizes a balloon to block feces from adversely affecting the anastomosis) to conduct a randomized, parallel-controlled trial. This study aims to further investigate the role of the modified TDT in preventing and treating anastomotic leakage following rectal surgery
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anastomotic Leak | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Modified Transanal Drainage Tube | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- mTDT Group
- description
- Patients will undergo elective laparoscopic/robotic low anterior resection and will be subjected to a modified perianal drainage tube intervention.
- interventionNames
- Device: Modified Transanal Drainage Tube
- type
- NO_INTERVENTION
- label
- Non-mTDT Group
- description
- Patients will undergo elective laparoscopic/robotic low anterior resection and will NOT be subjected to a modified perianal drainage tube intervention.
Primary outcomes (1)
- measure
- Incidence of AL
- timeFrame
- The time frame is from the completion of the surgery to the 30th day after the surgery.
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Rectal adenocarcinoma (confirmed by pathology); * Tumor location: The lower edge is ≤10 cm from the anal verge; * Age: ≥18 and ≤80 years old; * ASA ≤3 ; * After assessment, laparoscopic/robotic sphincter - preserving surgery for rectal cancer is feasible; * T2 - 4N0 - 2M0\~T0 - 1N1 - 2M0 \& non- local recurrence; * Signed informed consent form; * Able to understand the risks of participating in the trial. Exclusion Criteria: * Emergency surgery; * Presence of multiple primary colorectal cancers; * History of long - term use of immunosuppressants or corticosteroids; * Patients with severe mental illness or uncontrolled infection before surgery; * Pregnant or breastfeeding women; * Bowel obstruction before surgery; * BMI ≥35.0
References
Publications (1)
- RESULTZhao S, Zhang L, Gao F, Wu M, Zheng J, Bai L, Li F, Liu B, Pan Z, Liu J, Du K, Zhou X, Li C, Zhang A, Pu Z, Li Y, Feng B, Tong W. Transanal Drainage Tube Use for Preventing Anastomotic Leakage After Laparoscopic Low Anterior Resection in Patients With Rectal Cancer: A Randomized Clinical Trial. JAMA Surg. 2021 Dec 1;156(12):1151-1158. doi: 10.1001/jamasurg.2021.4568. PMID 34613330